Assignee
SHANGHAI VISONPHARMA CO LTD
CN·0 granted patents·4 pending applications·0 citations·filing 2021–2023
Top patents by PatentIndex Score
4 records- 0160US2025195524A1Pyrimido-pyridazinone compound as toll-like receptor agonistSHANGHAI VISONPHARMA CO LTD·Filed 2023·Application pending·0 cites
- 0259US2025059183A1Pyridine[4,3-d]pyrimidine compound as tlr7/8 agonistSHANGHAI VISONPHARMA CO LTD·Filed 2022·Application pending·0 cites
- 0354US2024124486A1Macrocyclic tlr7 agonist, preparation method therefor, pharmaceutical composition and use thereofSHANGHAI VISONPHARMA CO LTD·Filed 2021·Application pending·0 cites
- 0454US2024166649A1Dihydropyrimidine compound, preparation method therefor and application thereofSHANGHAI VISONPHARMA CO LTD·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SHANGHAI VISONPHARMA CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →